BSX•benzinga•April 23, 2025 at 10:35 AM

Boston Scientific Sees Q2 Adj EPS $0.71-$0.73 vs $0.71 Est and estimates net sales growth for the second quarter of 2025 to be in a range of approximately 17.5 to 19.5 percent on a reported basis versus the prior year period

No summary available.

Read the full article from the original source for complete details and context.

Article published on April 23, 2025 by benzinga